Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-18 2:51 pm Purchase | 2024-09-30 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 9,151,775 10.900% | 9,151,775 (New Position) | Filing History |
| 2024-02-13 5:08 pm Sale | 2023-12-29 | 13G | Laboratory Corporation of America Holdings LH | The Vanguard Group | 9,745,265 11.480% | -2,418,669 (-19.88%) | Filing History |
| 2024-01-30 2:38 pm Sale | 2023-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 10,488,875 12.400% | -2,867,451 (-21.47%) | Filing History |
| 2023-07-24 4:20 pm Sale | 2023-07-24 | 13D | Enzo Biochem, Inc. ENZ | LABCORP HOLDINGS INC. LH | 0 0.000% | -4,862,730 (Position Closed) | Filing History |
| 2023-03-27 4:32 pm Purchase | 2023-03-16 | 13D | Enzo Biochem, Inc. ENZ | LABCORP HOLDINGS INC. LH | 4,862,730 9.800% | 4,862,730 (New Position) | Filing History |
| 2023-02-10 11:28 am Unchanged | 2022-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 13,356,326 13.000% | 0 (Unchanged) | Filing History |
| 2023-02-09 11:25 am Sale | 2022-12-30 | 13G | Laboratory Corporation of America Holdings LH | The Vanguard Group | 12,163,934 11.790% | -352,634 (-2.82%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 13,356,326 13.000% | 0 (Unchanged) | Filing History |
| 2023-01-20 5:17 pm Purchase | 2022-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 13,356,326 13.000% | 2,057,912 (+18.21%) | Filing History |
| 2022-03-09 5:18 pm Purchase | 2022-02-28 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 11,298,414 10.400% | 1,666,999 (+17.31%) | Filing History |
| 2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | Laboratory Corporation of America Holdings LH | The Vanguard Group | 12,516,568 11.240% | 404,447 (+3.34%) | Filing History |
| 2022-02-01 5:14 pm Purchase | 2021-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 9,631,414 8.600% | 514,309 (+5.64%) | Filing History |
| 2021-02-10 11:14 am Sale | 2020-12-31 | 13G | Laboratory Corporation of America Holdings LH | The Vanguard Group | 12,112,121 10.680% | -565,995 (-4.46%) | Filing History |
| 2021-01-29 5:22 pm Sale | 2020-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 9,117,106 8.000% | -1,190,933 (-11.55%) | Filing History |
| 2020-02-11 7:14 pm Purchase | 2019-12-31 | 13G | Laboratory Corporation of America Holdings LH | The Vanguard Group | 12,678,116 11.210% | 12,931 (+0.10%) | Filing History |
| 2020-02-05 12:16 pm Sale | 2019-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 10,308,038 9.100% | -1,366,051 (-11.70%) | Filing History |